Interactions between oral contraceptive status and GSTM1 and GSTT1 deletions on insulin-like growth factor-1 (IGF-1) plasma levels in young healthy women

Abstract

Access to the published version may require journal subscription. Published with permission from: ElsevierInteractions between oral contraceptive status and GSTM1 and GSTT1 deletions on insulin-like growth factor-1 (IGF-1) plasma levels in young healthy women Abstract Objective: Insulin-like growth factor-1 (IGF-1) is essential for the pubertal growth spurt and for normal mammary gland development. IGF-1 increases premenopausal breast cancer risk. Oral contraceptives (OCs) decrease IGF-1 in most women. The endogenous estrogens and their metabolites also influence IGF-1 levels. Glutathione S-transferases (GSTs) are involved in estrogen metabolism. We aimed to study IGF-1 levels and body size in relation to GSTM1 and GSTT1 deletions, and GSTP1*1B and current oral contraceptive (OC) status. Design: Questionnaires on reproductive factors and OC use were completed and blood samples were obtained during menstrual cycle day 18-23 in healthy women (≤40 years) from breast cancer high-risk families. IGF-1 was analyzed with radioimmunoassay. Genetic analyses were done with PCR based methods. Initially 258 women were included. After exclusion 229 women were finally included in the analyses of IGF-1 in relation to GSTM1 and GSTT1. Results: Among the 142 non-OC users, GSTM1*0/*0 or GSTT1*0/*0 alone were associated with lower IGF-1 levels while homozygous GSTM1*0/*0/GSTT1*0/*0 carriers had higher IGF-1 levels (P interaction =0.024). In the 87 OC users, GSTM1*0/*0 or GSTT1*0/*0 alone were associated with higher IGF-1 levels while homozygous GSTM1*0/*0/GSTT1*0/*0 carriers had lower IGF-1 levels (P interaction =0.010). Among all 229 women, a three-way interaction model showed an interaction between the GSTM1*0/*0/GSTT1*0/*0 genotype and OC use on IGF-1 levels (P interaction =0.003). GSTP1*1B was not associated with IGF-1. The GSTM1*1/GSTT1*0/*0 genotype was associated with high body weight (P=0.003) and GSTM1*0/*0/GSTT1*0/*0 was associated with early growth (P=0.003). Conclusion: Both OC use and GSTT1 and GSTM1 genotypes may influence IGF-1 levels. Further studies are warranted to confirm our finding and elucidate the clinical importance.

Research Article Synergic effect of oral contraceptives, GSTP1 polymorphisms, and high-risk HPV infection in development of cervical lesions.

“…More than the metabolism of environmental carcinogens, GST gene products are also involved in estrogen metabolism (Henningson et al, 2010). So, variations in GST genes may be relevant in a condition of long-term exposure to synthetic estrogens, such as those observed in oral contraceptive users.…”

GSTM1 and GSTT1 copy number variants and the risk to Thai females of hepatocellular carcinoma

“…Prior research, which supports our results, identified GSTM1 CNVs and sex hormones as two factors that were associated with liver inflammation and carcinogenesis. GST polymorphisms were found to influence the efficiency of estrogen metabolism in women (25).…”

Genetic Polymorphisms of Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor Binding Protein 3, Xenoestrogen, Phytoestrogen, and Premenopausal Breast Cancer

“…The level of endogenous estrogen has reportedly been positively associated with igf-1 expression 15 . Estradiol might elevate growth hormone-mediated expression of igf-1 messenger rna in normal mammary tissue by a factor of 4-6 and elevate igf-1 bioactivity by downregulating igfbp-3 synthesis 16 .…”